Grifols, S.A. (GRFS) Social Stream



Grifols, S.A. (GRFS): $13.08

0.12 (+0.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Grifols SA (GRFS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GRFS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-05 3 $17.7 $17.7 $17.7 $11.68 51.54%
2021-11-14 4 $19.2 $17.7 $18.45 $11.68 57.96%
2022-01-04 3 $12.5 $12.5 $12.5 $11.68 7.02%
2022-03-04 3 $13 $13 $13 $11.68 11.3%

The Trend in the Analyst Price Target


Over the past 23 months, GRFS's average price target has gone down $15.83.

GRFS reports an average of 25.7% for its upside potential over the past 30 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 3 17.7 17.7 17.70 15.14 16.91%
2021-10-14 4 19.2 17.7 18.45 14.15 30.39%
2021-11-14 4 19.2 17.7 18.45 11.98 54.01%
2022-01-04 3 12.5 12.5 12.50 11.28 10.82%
2022-03-04 3 13.0 13.0 13.00 11.17 16.38%

GRFS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 0 1 1 1 3

The Trend in the Broker Recommendations


Over the past 30 weeks, GRFS's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Grifols SA's variance in analysts' estimates is lower than 90.48% of them.
  • GRFS has a higher number of analysts covering the stock than 11.1% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, Grifols SA's average analyst price target is higher than 24.1% of them.
  • Grifols SA's upside potential (average analyst target price relative to current price) is greater than 55.59% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, GMAB, GLPG, and ENDP are the three stocks most similar to Grifols SA regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding GRFS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7338 seconds.